Novo Nordisk Tishha News

Temasek-Backed Manipal Health files for IPO Amid Healthcare Demand Surge

tishha_newsMarch 24, 2026March 24, 202602 mins

Manipal Health Enterprises has announced plans to raise ₹8,000 crore (about $852 million) through a fresh share issuance as part…

Dr Reddy’s Launches Low-Cost Semaglutide Generic ‘Obeda’ in India’s Booming GLP-1 Market

tishha_newsMarch 23, 2026March 23, 202603 mins

Dr. Reddy’s Laboratories has entered the fast-growing GLP-1 therapy segment with the launch of its semaglutide generic, Obeda, for Type…

Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India

tishha_newsMarch 17, 2026March 17, 202604 mins

The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…

Dr Reddy’s Plans Up to 60% Cheaper Generic Version of Wegovy as Patent Nears Expiry

tishha_newsFebruary 18, 2026February 18, 202603 mins

India’s Dr Reddy’s Laboratories is preparing to introduce a significantly lower-priced generic version of blockbuster weight-loss drug Wegovy, currently sold…

Novo Nordisk Reduces Wegovy Prices in China Amid Rising Competition

tishha_newsDecember 30, 2025December 30, 202503 mins

Novo Nordisk has announced a reduction in the price of its blockbuster weight-loss drug Wegovy in China, as the Danish…

Emcure Pharma Launches Semaglutide-Based Weight Loss Drug Poviztra in India

tishha_newsDecember 22, 2025December 22, 202502 mins

Emcure Pharmaceuticals has announced the nationwide commercial rollout of Poviztra, a semaglutide-based injection indicated for weight management. With this launch,…

Novo Nordisk Rolls out Ozempic in India at ₹2,200 per Week Amid Patent Disputes

tishha_newsDecember 16, 2025December 16, 202504 mins

Novo Nordisk, the Denmark-based pharmaceutical major, has formally introduced its widely used diabetes and weight-management drug Ozempic in the Indian…